Breaking News From Pharma & Bio Ingredients
Shengtai Pharmaceutical testing new Glucose Plant
Posted on 2008-06-19 16:42:00
Shengtai Pharmaceutical has nearly finished the construction of the new glucose production complex with expected annual production capacity of 120,000 metric tons. The new facility has been equipped with state-of-the-art, high-tech operational machines and since May 2008, the Company successfully launched trial production of glucose products. This facility combined with the Company's existing glucose facility will provide total production capacity of 210,000 metric tons of glucose per year. Once the plant is fully operational, Shengtai's glucose quality will be able to match that produced in the rest of the world.
The trial production and quality tests are categorized by products — food and beverage grade glucose, monohydrate glucose and anhydrous glucose. The Company has adopted a series of production and quality control tests to measure the results of the trial production stage, including pH scale, specific gravity, DE scale, temperature and luminousness.
The trial production results for food and beverage grade glucose were the first to pass the tests due to their relatively lower testing standards. Monohydrate glucose and anhydrous glucose products are still in trial production and undergoing quality control tests due to their higher testing standards. The Company still needs to install supplemental equipment to complete their tests.
Subscribe via RSS
